Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 519

1.

Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes.

Posch W, Cardinaud S, Hamimi C, Fletcher A, Mühlbacher A, Loacker K, Eichberger P, Dierich MP, Pancino G, Lass-Flörl C, Moris A, Saez-Cirion A, Wilflingseder D.

J Allergy Clin Immunol. 2012 Dec;130(6):1368-74.e2. doi: 10.1016/j.jaci.2012.08.025. Epub 2012 Oct 11.

2.

Candida albicans Hgt1p, a multifunctional evasion molecule: complement inhibitor, CR3 analogue, and human immunodeficiency virus-binding molecule.

Lesiak-Markowicz I, Vogl G, Schwarzmüller T, Speth C, Lass-Flörl C, Dierich MP, Kuchler K, Würzner R.

J Infect Dis. 2011 Sep 1;204(5):802-9. doi: 10.1093/infdis/jir455.

3.

Absence of indigenous specific West Nile virus antibodies in Tyrolean blood donors.

Sonnleitner ST, Simeoni J, Schmutzhard E, Niedrig M, Ploner F, Schennach H, Dierich MP, Walder G.

Eur J Clin Microbiol Infect Dis. 2012 Jan;31(1):77-81. doi: 10.1007/s10096-011-1279-x. Epub 2011 May 10.

PMID:
21556676
4.

Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs.

Bánki Z, Posch W, Ejaz A, Oberhauser V, Willey S, Gassner C, Stoiber H, Dittmer U, Dierich MP, Hasenkrug KJ, Wilflingseder D.

PLoS Pathog. 2010 Apr 29;6(4):e1000891. doi: 10.1371/journal.ppat.1000891.

5.

Potential synergistic activity of antimycotic substances in combination with human platelets against Aspergillus fumigatus.

Perkhofer S, Trappl K, Nussbaumer W, Dierich MP, Lass-Flörl C.

J Antimicrob Chemother. 2010 Jun;65(6):1309-11. doi: 10.1093/jac/dkq111. Epub 2010 Apr 8. No abstract available.

PMID:
20378674
6.

Analysis of humoral immune responses in rhesus macaques vaccinated with attenuated SIVmac239Deltanef and challenged with pathogenic SIVmac251.

Freissmuth D, Hiltgartner A, Stahl-Hennig C, Fuchs D, Tenner-Racz K, Racz P, Uberla K, Strasak A, Dierich MP, Stoiber H, Falkensammer B.

J Med Primatol. 2010 Apr;39(2):97-111. doi: 10.1111/j.1600-0684.2009.00398.x. Epub 2009 Dec 9.

PMID:
20015159
7.

Induction of complement-mediated lysis of HIV-1 by a combination of HIV-specific and HLA allotype-specific antibodies.

Hildgartner A, Wilflingseder D, Gassner C, Dierich MP, Stoiber H, Bánki Z.

Immunol Lett. 2009 Sep 22;126(1-2):85-90. doi: 10.1016/j.imlet.2009.08.005. Epub 2009 Aug 19.

PMID:
19698750
8.

Potential antifungal effects of human platelets against zygomycetes in vitro.

Perkhofer S, Kainzner B, Kehrel BE, Dierich MP, Nussbaumer W, Lass-Flörl C.

J Infect Dis. 2009 Oct 1;200(7):1176-9. doi: 10.1086/605607.

9.

Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.

Orth D, Khan AB, Naim A, Grif K, Brockmeyer J, Karch H, Joannidis M, Clark SJ, Day AJ, Fidanzi S, Stoiber H, Dierich MP, Zimmerhackl LB, Würzner R.

J Immunol. 2009 May 15;182(10):6394-400. doi: 10.4049/jimmunol.0900151.

10.

Complement and antibodies: a dangerous liaison in HIV infection?

Stoiber H, Soederholm A, Wilflingseder D, Gusenbauer S, Hildgartner A, Dierich MP.

Vaccine. 2008 Dec 30;26 Suppl 8:I79-85. Review.

PMID:
19388170
11.

A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates.

Blum G, Perkhofer S, Grif K, Mayr A, Kropshofer G, Nachbaur D, Kafka-Ritsch R, Dierich MP, Lass-Flörl C.

Clin Microbiol Infect. 2008 Dec;14(12):1146-51. doi: 10.1111/j.1469-0691.2008.02099.x.

12.

Serine protease espP subtype alpha, but not beta or gamma, of Shiga toxin-producing Escherichia coli is associated with highly pathogenic serogroups.

Khan AB, Naim A, Orth D, Grif K, Mohsin M, Prager R, Dierich MP, Würzner R.

Int J Med Microbiol. 2009 Apr;299(4):247-54. doi: 10.1016/j.ijmm.2008.08.006. Epub 2008 Nov 25.

PMID:
19036636
13.

Complement induction and complement evasion in patients with cerebral aspergillosis.

Rambach G, Maier H, Vago G, Mohsenipour I, Lass-Flörl C, Defant A, Würzner R, Dierich MP, Speth C.

Microbes Infect. 2008 Nov-Dec;10(14-15):1567-76. doi: 10.1016/j.micinf.2008.09.011. Epub 2008 Oct 14.

PMID:
18977454
14.

Human platelets attenuate Aspergillus species via granule-dependent mechanisms.

Perkhofer S, Kehrel BE, Dierich MP, Donnelly JP, Nussbaumer W, Hofmann J, von Eiff C, Lass-Flörl C.

J Infect Dis. 2008 Oct 15;198(8):1243-6. doi: 10.1086/591458.

15.

Ointments as a source of meticillin-resistant Staphylococcus aureus spread.

Grif K, Orth D, Mayr A, Dierich MP, Würzner R, Lass-Flörl C, Nogler-Semenitz E.

J Hosp Infect. 2008 Oct;70(2):195-7. doi: 10.1016/j.jhin.2008.06.011. Epub 2008 Aug 23. No abstract available.

PMID:
18723250
16.

Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.

Perkhofer S, Locher M, Cuenca-Estrella M, Rüchel R, Würzner R, Dierich MP, Lass-Flörl C.

Antimicrob Agents Chemother. 2008 Jul;52(7):2636-8. doi: 10.1128/AAC.00492-08. Epub 2008 May 5.

17.

Basidiomycete metabolites attenuate virulence properties of Candida albicans in vitro.

Falkensammer B, Pleyer L, Ressler S, Berg A, Borg-von Zepelin M, Nagl M, Lass-Flörl C, Speth C, Dierich MP, Würzner R.

Mycoses. 2008 Nov;51(6):505-14. doi: 10.1111/j.1439-0507.2008.01515.x. Epub 2008 Apr 16.

18.

Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions.

Perkhofer S, Jost D, Dierich MP, Lass-Flörl C.

Antimicrob Agents Chemother. 2008 May;52(5):1873-5. doi: 10.1128/AAC.01572-07. Epub 2008 Mar 17.

19.

Potential basis for amphotericin B resistance in Aspergillus terreus.

Blum G, Perkhofer S, Haas H, Schrettl M, Würzner R, Dierich MP, Lass-Flörl C.

Antimicrob Agents Chemother. 2008 Apr;52(4):1553-5. doi: 10.1128/AAC.01280-07. Epub 2008 Feb 11.

20.

Complement-HIV interactions during all steps of viral pathogenesis.

Stoiber H, Banki Z, Wilflingseder D, Dierich MP.

Vaccine. 2008 Jun 6;26(24):3046-54. doi: 10.1016/j.vaccine.2007.12.003. Epub 2007 Dec 26.

PMID:
18191309
21.

The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.

Orth D, Grif K, Khan AB, Naim A, Dierich MP, Würzner R.

Diagn Microbiol Infect Dis. 2007 Nov;59(3):235-42. Epub 2007 Oct 10.

PMID:
17931818
22.

Bacterial contamination of solutions for parenteral administration for single- and multiple-dose vials after multiple use in the hospital.

Nogler-Semenitz E, Lass-Flörl C, Nogler M, Speer G, Dierich MP.

Wien Med Wochenschr. 2007;157(15-16):398-401.

PMID:
17922089
23.

Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein.

Vogl G, Lesiak I, Jensen DB, Perkhofer S, Eck R, Speth C, Lass-Flörl C, Zipfel PF, Blom AM, Dierich MP, Würzner R.

Mol Immunol. 2008 Mar;45(5):1485-93. Epub 2007 Oct 25.

24.

Prevalence of Shiga toxin-, intimin- and haemolysin genes in Escherichia coli isolates from drinking water supplies in a rural area of Austria.

Halabi M, Orth D, Grif K, Wiesholzer-Pittl M, Kainz M, Schöberl J, Dierich MP, Allerberger F, Würzner R.

Int J Hyg Environ Health. 2008 Jul;211(3-4):454-7. Epub 2007 Sep 21.

PMID:
17889605
25.

HIV-1 induced generation of C5a attracts immature dendriticcells and promotes infection of autologous T cells.

Soederholm A, Bánki Z, Wilflingseder D, Gassner C, Zwirner J, López-Trascasa M, Falkensammer B, Dierich MP, Stoiber H.

Eur J Immunol. 2007 Aug;37(8):2156-63.

26.

IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells.

Wilflingseder D, Banki Z, Garcia E, Pruenster M, Pfister G, Muellauer B, Nikolic DS, Gassner C, Ammann CG, Dierich MP, Piguet V, Stoiber H.

J Immunol. 2007 Jun 15;178(12):7840-8.

27.
28.

Influence of amphotericin B and amphotericin B colloidal dispersion on the functions of human phagocytes in defence against Aspergillus species.

Perkhofer S, Blum G, Speth C, Mayr A, Dierich MP, Lass-Flörl C.

Eur J Clin Microbiol Infect Dis. 2007 Jun;26(6):413-7.

PMID:
17486378
29.

Absent reduction by HIV protease inhibitors of Candida albicans adhesion to endothelial cells.

Falkensammer B, Pilz G, Bektić J, Imwidthaya P, Jöhrer K, Speth C, Lass-Flörl C, Dierich MP, Würzner R.

Mycoses. 2007 May;50(3):172-7.

30.

In vitro determination of phagocytosis and intracellular killing of Aspergillus species by mononuclear phagocytes.

Perkhofer S, Speth C, Dierich MP, Lass-Flörl C.

Mycopathologia. 2007 Jun;163(6):303-7. Epub 2007 Apr 26.

PMID:
17458710
31.

Subtype and genotypic resistance analysis of HIV-1 infected patients in Austria.

Falkensammer B, Doerler M, Kessler HH, Puchhammer-Stoeckl E, Parson W, Duftner C, Dierich MP, Stoiber H.

Wien Klin Wochenschr. 2007;119(5-6):181-5.

PMID:
17427022
32.

Variability in tellurite resistance and the ter gene cluster among Shiga toxin-producing Escherichia coli isolated from humans, animals and food.

Orth D, Grif K, Dierich MP, Würzner R.

Res Microbiol. 2007 Mar;158(2):105-11. Epub 2006 Dec 20.

PMID:
17317110
33.

Interaction of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro.

Perkhofer S, Niederegger H, Blum G, Burgstaller W, Ledochowski M, Dierich MP, Lass-Flörl C.

Int J Antimicrob Agents. 2007 Apr;29(4):424-9. Epub 2007 Feb 2.

34.

Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease.

Scherl M, Posch U, Obermoser G, Ammann C, Sepp N, Ulmer H, Dierich MP, Stoiber H, Falkensammer B.

Lupus. 2006;15(12):865-72.

PMID:
17211992
35.

Co-infection with two Chlamydophila species in a case of fulminant myocarditis.

Walder G, Gritsch W, Wiedermann CJ, Pölzl G, Laufer G, Hotzel H, Berndt A, Pankuweit S, Theegarten D, Anhenn O, Oehme A, Dierich MP, Würzner R.

Crit Care Med. 2007 Feb;35(2):623-6.

PMID:
17204998
36.

Changes in HIV-specific antibody responses and neutralization titers in patients under ART.

Falkensammer B, Freissmuth D, Hübner L, Speth C, Dierich MP, Stoiber H.

Front Biosci. 2007 Jan 1;12:2148-58.

PMID:
17127452
37.

A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum.

Stahl-Hennig C, Eisenblatter M, Franz M, Stoiber H, Tenner-Racz K, Suh YS, Jasny E, Falkensammer B, Ugucchioni M, Georgsson G, Baroni C, Dierich MP, Lifson JD, Steinman RM, Uberla K, Racz P, Ignatius R.

Front Biosci. 2007 Jan 1;12:2107-23.

PMID:
17127448
38.

Tracing complement-retroviral interactions from mucosal surfaces to the lymphatic tissue.

Banki Z, Soederholm A, Mullauer B, Dierich MP, Stoiber H.

Front Biosci. 2007 Jan 1;12:2096-106. Review.

PMID:
17127447
39.

Immune response to retroviral infections of the brain.

Speth C, Rambach G, Hagleitner M, Konstanzer K, Höllmüller I, Dierich MP, Mohsenipour I, Maier H.

Front Biosci. 2007 Jan 1;12:1508-19. Review.

PMID:
17127398
40.

Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro.

Perkhofer S, Lugger H, Dierich MP, Lass-Flörl C.

Antimicrob Agents Chemother. 2007 Feb;51(2):791-3. Epub 2006 Nov 20.

41.

Emerging Shiga toxin-producing Escherichia coli serotypes in Europe: O100:H- and O127:H40.

Orth D, Grif K, Fisher I, Fruth A, Tschäpe H, Scheutz F, Dierich MP, Würzner R.

Curr Microbiol. 2006 Nov;53(5):428-9. Epub 2006 Oct 19.

PMID:
17066335
42.

A plea for justice for jailed medical workers.

Ahuja SK, Aiuti F, Berkhout B, Biberfeld P, Burton DR, Colizzi V, Deeks SG, Desrosiers RC, Dierich MP, Doms RW, Emerman M, Gallo RC, Girard M, Greene WC, Hoxie JA, Hunter E, Klein G, Korber B, Kuritzkes DR, Lederman MM, Malim MH, Marx PA, McCune JM, McMichael A, Miller C, Miller V, Montagnier L, Montefiori DC, Moore JP, Nixon DF, Overbaugh J, Pauza CD, Richman DD, Saag MS, Sattentau Q, Schooley RT, Shattock R, Shaw GM, Stevenson M, Trkola A, Wainberg MA, Weiss RA, Wolinsky S, Zack JA.

Science. 2006 Nov 10;314(5801):924-5. Epub 2006 Oct 24. No abstract available.

PMID:
17062652
43.

Cytolethal distending toxins in Shiga toxin-producing Escherichia coli: alleles, serotype distribution and biological effects.

Orth D, Grif K, Dierich MP, Würzner R.

J Med Microbiol. 2006 Nov;55(Pt 11):1487-92.

PMID:
17030906
44.

Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells.

Bánki Z, Wilflingseder D, Ammann CG, Pruenster M, Müllauer B, Holländer K, Meyer M, Sprinzl GM, van Lunzen J, Stellbrink HJ, Dierich MP, Stoiber H.

J Immunol. 2006 Sep 1;177(5):3469-76.

45.

Prevalence, structure and expression of urease genes in Shiga toxin-producing Escherichia coli from humans and the environment.

Orth D, Grif K, Dierich MP, Würzner R.

Int J Hyg Environ Health. 2006 Nov;209(6):513-20. Epub 2006 Jul 31.

PMID:
16877040
46.

Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy.

Bjørge L, Stoiber H, Dierich MP, Meri S.

Scand J Immunol. 2006 May;63(5):355-64.

47.

Human granulocytic anaplasmosis in Austria: epidemiological, clinical, and laboratory findings in five consecutive patients from Tyrol, Austria.

Walder G, Fuchs D, Sarcletti M, Berek K, Falkensammer B, Huber K, Petrovec M, Dierich MP, Würzner R.

Int J Med Microbiol. 2006 May;296 Suppl 40:297-301. Epub 2006 Mar 10.

PMID:
16531117
48.

Serological evidence for tick-borne encephalitis, borreliosis, and human granulocytic anaplasmosis in Mongolia.

Walder G, Lkhamsuren E, Shagdar A, Bataa J, Batmunkh T, Orth D, Heinz FX, Danichova GA, Khasnatinov MA, Würzner R, Dierich MP.

Int J Med Microbiol. 2006 May;296 Suppl 40:69-75. Epub 2006 Mar 9.

PMID:
16524782
49.

Characterization of methicillin-resistant Staphylococcus aureus from Ulaanbaatar, Mongolia.

Orth D, Grif K, Erdenechimeg L, Battogtokh C, Hosbayar T, Strommenger B, Cuny C, Walder G, Lass-Flörl C, Dierich MP, Witte W.

Eur J Clin Microbiol Infect Dis. 2006 Feb;25(2):104-7.

PMID:
16498522
50.

Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157: indications for an animal reservoir.

Orth D, Grif K, Dierich MP, Würzner R.

Epidemiol Infect. 2006 Aug;134(4):719-23. Epub 2005 Dec 22.

Supplemental Content

Loading ...
Support Center